E. Coli Flashcards

Questions to ask How can u prevent it? is there a vaccine? Who's at risk/ what's the epi? How do u treat it? how do u diagnose it? Pathogensis? symptoms/ disease? I. Mechanisms of Pathogenesis A. Type 3 Secretion System (T3SS) common pathogenic mechanisms emerge, including interference with the host cell cytoskeleton to promote attachment and invasion, interference with cellular trafficking processes, cytotoxicity and barrier dysfunction, and immune system subversion. http://cmr (36 cards)

1
Q

STEC

A

shiga-toxin producing E.Coli

also known as EHEC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

EHEC

A

enterohemorrhagic

only hemhorragic strain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

EPEC

A

enteropathogenic e. coli

diarrheogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

EAEC

A

enteroaggregative e. coli

diarrheogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

EIEC

A

enteroinvasive e. coli

diarrheogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ETEC

A

enterotoxigenic e. coli

diarrheogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

path: HUS- hemolytic uremic syndrome

A

the infection stimulates platelet formation in microvasculature. movement past the platelets shears red blood cells

shishtocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

path: microangiopathy

A

platelets lodged in microvasculature shear RBCs into fragments called schistocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

path: schistocytes

A

red blood cell fragments produced during HUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

path: T3SS

A

Type III Secretion System

bacteria are able to directly inject bacterial proteins called effectors into host cells across bacterial and host membranes, where they can manipulate host cell function.

common pathogenic mechanisms emerge, including interference with the host cell cytoskeleton to promote attachment and invasion, interference with cellular trafficking processes, cytotoxicity and barrier dysfunction, and immune system subversion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

path: G3b

A

the receptor for shiga toxin (vascular endothelium)

*cattle are different/ resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

path: STX (shiga-like toxin) B subunit

A

binding subunit (vascular endothelium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

path: STX (shiga-like toxin) A subunit

A

halts protein synthesis inside vascular endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

path: LEE

A

locus of enterocyte effacement

a pathogenecity island

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

path: T3SS effectors

A

injected proteins

ex. tir and intimin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

path: RTX

A

repeats in toxin

pore forming proteins

17
Q

path: k-antigen

18
Q

path: LT toxin

A

targets cAMP and leads to excess secretion of Cl- secretion

*similar to cholera toxin

19
Q

EAST

A

enteroaggregative stable toxin

20
Q

path: plasmid encoded toxin

A

poorly characterized

21
Q

EHEC: path

A
  1. shiga toxin
  2. hemolysins
  3. A/E
22
Q

EPEC: path

23
Q

ETEC: path

A
  1. ST: heat-stable toxin
  2. LT; heat labile toxin
  3. fimbrae
24
Q

EAEC: path

A
  1. hemolysins

2. EAST

25
EIEC: path
1. nonfimbrae adhesins
26
DAEC: path
diffuse-adherence factors
27
DAEC: presentation
diarrhea in children
28
EIEC: presentation
watery diarrhea with blood and mucus
29
EPEC: presentation
infantile diarrhea
30
ETEC: presentation
traveler's diarrhea
31
EHEC: presentation
1. bloody diarrhea | 2. HUS
32
EAEC: presentation
EPEC | watery diarrhea in children of developing countries
33
EHEC: treatment
supportive care only
34
ETEC: treatment
1. loperamide 2. azithromycin 3. rifaximin
35
EPEC: treatment
anti-biotics based on susceptibility tesitng
36
EAEC: treatment
fluorquinolones